Frequent Ivermectin Use Upregulates ABC Transporter Genes Leading to Long-Term Health Risks

Medical News: Ivermectin, a widely used antiparasitic agent, has been a subject of intense discussion in recent years. Although originally developed to treat parasitic infections, its off-label use for COVID-19 has surged - prompting concerns about potential long-term effects. One area of interest is the possible upregulation of ATP-binding cassette (ABC) transporter genes due to frequent ivermectin consumption. This Medical News report delves into the background of ivermectin, explores the function of ABC transporters, examines the potential link between prolonged ivermectin use and gene expression changes, and discusses the implications for long-term health.


Frequent Ivermectin Use Upregulates ABC Transporter Genes Leading to Long-Term Health Risks

Ivermectin: Therapeutic Uses and Emerging Concerns
Ivermectin is primarily recognized for its effectiveness against a variety of parasitic infections in both humans and animals. It has been approved for conditions such as onchocerciasis, strongyloidiasis, and scabies. However, in recent years, its use has expanded beyond these traditional applications. The drug gained media attention and became a subject of public debate during the COVID-19 pandemic when some promoted it as a treatment option.
 
With this increase in usage, some researchers have begun to investigate not only the benefits of ivermectin but also its potential side effects - especially when used in higher doses or over extended periods. One emerging hypothesis is that frequent ivermectin use might alter the expression of genes responsible for drug transport and metabolism, particularly the ATP-binding cassette (ABC) transporters.
 
Understanding ABC Transporter Genes
ABC transporters are a large family of proteins found in all living organisms. These proteins play a critical role in cellular processes by transporting a wide range of molecules across cell membranes. They are essential in pharmacokinetics, influencing the absorption, distribution, and excretion of drugs. When these transporters are upregulated, they can enhance the cell's ability to expel substances, which might affect the efficacy and toxicity of various medications.
 
In the context of drug interactions, the upregulation of ABC transporters can lead to multidrug resistance - a phenomenon well documented in cancer cells, where it complicates treatment by reducing the intracellular concentration of chemotherapeutic agents. The possibility that ivermectin could similarly trigger changes in ABC transporter gene expression raises questions about its long-term safety profile.
 
The Link Between Ivermectin and ABC Transporter Upregulation
Recent research has suggested that ivermectin, especially when used frequently or at higher doses than recommended, might cause the upregulation of ABC transporter genes. This hypothesis is based on the understanding that the body’s exposure to certain xenobiotics (foreign substances) can trigger a defense mechanism. In response to prolonged exposure, cells may increase the pro duction of transporters to efficiently eliminate the compound.
 
While definitive clinical evidence linking ivermectin to ABC transporter upregulation is still limited, several experimental studies in cellular models have indicated that ivermectin may indeed influence gene expression patterns. The mechanistic details remain under investigation, but the working theory is that ivermectin interacts with nuclear receptors or other transcription factors that regulate ABC transporter genes. Consequently, an increase in these transporters could alter the pharmacodynamics of other drugs and impact cellular detoxification pathways.
 
Potential Long Term Health Implications
If frequent ivermectin use does lead to sustained upregulation of ABC transporter genes, several long-term health issues might arise:
 
-Altered Drug Metabolism: An increase in ABC transporters could lead to faster clearance of various drugs from the body. This might reduce the therapeutic efficacy of medications, necessitating higher doses or alternative treatments. Patients on chronic medications for conditions like epilepsy, hypertension, or cancer could be particularly affected.
 
-Drug-Drug Interactions: Upregulated ABC transporters may affect the absorption and excretion of multiple drugs concurrently. This could result in unexpected drug interactions, complicating the management of polypharmacy, especially in elderly patients or those with chronic illnesses.
 
-Resistance to Therapy: As seen in oncology, the enhanced efflux of therapeutic agents from cells can contribute to drug resistance. A similar mechanism in other contexts might lead to decreased responsiveness to treatment regimens for a range of conditions.
 
-Cellular Homeostasis: ABC transporters are also involved in maintaining cellular homeostasis by regulating lipid metabolism, hormone transport, and the removal of toxic metabolites. Their dysregulation might disrupt these processes, potentially leading to metabolic imbalances and increased susceptibility to other health issues over time.
 
Current Evidence and the Need for Further Research
At this stage, the link between frequent ivermectin use and the upregulation of ABC transporter genes remains a topic of ongoing research. While preliminary studies provide a basis for concern, more comprehensive clinical trials and observational studies are needed to conclusively determine the long-term impact on human health. It is crucial for the scientific community to explore these mechanisms further to ensure that the benefits of ivermectin are not outweighed by unforeseen adverse effects.
 
In light of these concerns, medical practitioners and researchers emphasize the importance of adhering to established dosing guidelines and avoiding off-label usage unless supported by robust clinical evidence. Additionally, patients are encouraged to consult healthcare professionals before starting or continuing any medication regimen, particularly when it involves drugs with potential systemic effects.
 
Conclusion
Ivermectin remains a valuable tool in the fight against parasitic diseases; however, its extended use - especially outside of approved indications - raises important questions about long-term safety. The potential upregulation of ABC transporter genes represents one area of concern, with implications ranging from altered drug metabolism to the development of multidrug resistance. While current evidence is still evolving, the hypothesis that frequent ivermectin usage could lead to significant changes in gene expression underscores the need for cautious application and further scientific inquiry.
 
As researchers continue to unravel the complex interactions between ivermectin and cellular defense mechanisms, healthcare providers must balance the immediate benefits of treatment with potential long-term risks. Ongoing studies will be crucial in providing a clearer understanding of how frequent use may affect ABC transporter gene expression and overall health, ensuring that both patients and practitioners are well informed when making treatment decisions.
 
This is an exclusive article for Thailand Medical News written by Nikhil Prasad
 
For the latest on adverse effects of prolonged usage of Ivermectin, keep on logging to Thailand Medical News.
 
Disclaimer: This article is intended for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before making decisions related to medication and treatment.
 
References:
 
https://www.ajtmh.org/view/journals/tpmd/105/4/article-p1117.xml
 
https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-016-1806-9
 
https://www.sciencedirect.com/science/article/abs/pii/S0014299914005032
 
https://www.sciencedirect.com/science/article/abs/pii/S0304401712003524
 
https://www.nature.com/articles/nrmicro1048
 
https://www.mdpi.com/2075-4450/11/5/280
 
https://www.nature.com/articles/s41598-019-52402-3
 
https://www.scielo.br/j/gmb/a/KdqhcVknwKw73jftTbRsH5N/?lang=en
 
https://www.cell.com/trends/molecular-medicine/fulltext/S1471-4914(22)00291-X
 
https://journals.lww.com/hep/abstract/2012/03000/adenosine_triphosphate_binding_cassette.19.aspx
 
https://journals.asm.org/doi/full/10.1128/aac.00713-16
 
https://www.sciencedirect.com/science/article/abs/pii/S0014489415001666
 
https://www.nature.com/articles/nrc706
 
https://www.cell.com/trends/molecular-medicine/fulltext/S1471-4914(22)00291-X
 
https://www.ncbi.nlm.nih.gov/books/NBK3/
 
https://humgenomics.biomedcentral.com/articles/10.1186/1479-7364-3-3-281
 
Read Also:
https://www.thailandmedical.news/news/breaking-ivermectin-users-will-likely-suffer-severe-or-lethal-mpox-infection-due-to-diminished-interferon-gamma
 
https://www.thailandmedical.news/news/brazilian-study-reveals-that-usage-of-antiparasitic-drug,-ivermectin-can-lead-to-gut-dysbiosis-and-liver-damage
 
https://www.thailandmedical.news/news/breaking-extensive-ivermectin-misuse-during-the-covid-19-pandemic-is-possibly-leading-to-rising-cases-of-drug-resistant-scabies
 
https://www.thailandmedical.news/pages/thailand_doctors_listings